Cargando…
Regarding: ‘Epoetin β treatment in patients with cancer chemotherapy induced anaemia: the impact of initial haemoglobin and target haemoglobin levels on survival, tumour progression and thromboembolic events’
Autor principal: | Schwarzer, G |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2795440/ https://www.ncbi.nlm.nih.gov/pubmed/19997108 http://dx.doi.org/10.1038/sj.bjc.6605474 |
Ejemplares similares
-
Epoetin-β treatment in patients with cancer chemotherapy-induced anaemia: the impact of initial haemoglobin and target haemoglobin levels on survival, tumour progression and thromboembolic events
por: Aapro, M, et al.
Publicado: (2009) -
Haemoglobin and anaemia in the SMART study
por: Mocroft, A, et al.
Publicado: (2010) -
Foetal Haemoglobin, Erythrocytes Containing Foetal Haemoglobin, and Hematological Features in Congolese Patients with Sickle Cell Anaemia
por: Tshilolo, L., et al.
Publicado: (2012) -
Sickle haemoglobin, haemoglobin C and malaria mortality feedbacks
por: Gonçalves, Bronner P., et al.
Publicado: (2016) -
Evaluation of the Performance of Haemoglobin Colour Scale and Comparison with HemoCue Haemoglobin Assay in Diagnosing Childhood Anaemia: A Field Validation Study
por: Ughasoro, Maduka Donatus, et al.
Publicado: (2019)